EXT1 and EXT2 are two genes that help bones grow normally. Changes in either gene cause a condition called hereditary multiple osteochondromas. People with this condition develop many bony growths, called osteochondromas, during childhood. Pathologists see these genes mentioned in reports on osteochondromas and on chondrosarcomas that grow from them.
This article explains what the EXT1 and EXT2 genes do, how changes in them cause hereditary multiple osteochondromas, and how doctors test for these changes.
The EXT1 and EXT2 genes hold the instructions for two proteins, exostosin-1 and exostosin-2. The two proteins work together. They help build a sugar-coated molecule called heparan sulfate.
Heparan sulfate helps control how cartilage cells grow and turn into bone. This process happens at the growth plates, the areas near the ends of long bones where children’s bones grow. Without enough heparan sulfate, some cartilage cells grow in the wrong direction. They form a bony bump that sticks out from the side of the bone.
EXT1 sits on chromosome 8, and EXT2 sits on chromosome 11.
An osteochondroma is a noncancerous bony growth covered by a cap of cartilage. It grows outward from the surface of a bone, usually near a growth plate. Osteochondromas often form near the knee, shoulder, or hip. They stop growing when a person stops growing.
Most people with an osteochondroma have only one. Fewer people have many, usually because of a change in EXT1 or EXT2.
Hereditary multiple osteochondromas is a condition in which a person develops many osteochondromas. It is also called hereditary multiple exostoses. The condition affects at least 1 in 50,000 to 100,000 people.
A change, or mutation, in one copy of EXT1 or EXT2 causes the condition:
The growths can cause pain, uneven limb length, bowed bones, shorter height, and limited joint movement. Surgeons may remove growths that cause problems.
Hereditary multiple osteochondromas follows an autosomal dominant pattern. One changed copy of EXT1 or EXT2 is enough to cause the condition. A parent with the condition has a 50 percent chance of passing it to each child.
About 90 percent of people inherit the change from a parent. In about 10 percent, the change is new and appears for the first time in that person.
A tumor forms when a growth-plate cell also loses its second, healthy copy of the gene. This second change happens only in that cell and the growth that comes from it.
Rarely, an osteochondroma can turn into a cancer called chondrosarcoma. The risk is higher in people with hereditary multiple osteochondromas than in people with a single growth. Lifetime risk estimates range from about 2 to 10 percent.
Most of these cancers are low grade, such as grade 1 chondrosarcoma. They usually grow from the cartilage cap of an osteochondroma. Warning signs include a growth that gets larger or starts to hurt after a person has stopped growing.
The pathologist examines a removed growth under the microscope. The pathologist looks for features that separate a noncancerous osteochondroma from a chondrosarcoma.
Doctors test for EXT1 and EXT2 changes with a genetic test, usually on a blood or saliva sample. The test looks for changes present from birth. Genetic testing can confirm the diagnosis and help identify family members who carry the same change.
A pathology report on an osteochondroma does not usually include EXT1 or EXT2 results. The report describes the growth itself. Your doctor may suggest genetic testing if you have several osteochondromas or a family history.
🔍 Search MyPathologyReport
Type what you see on your report — for example a diagnosis or test name